Switzerland has joined an unprecedented scientific collaboration between Europe and the United States to accelerate nanomedicine testing in a bid to conquer a common enemy: cancer.
Many of us take medicines’ side effects for granted as the price to pay for getting better. But some side effects, which occur when disease-fighting drugs damage healthy tissues in the cross-fire, may become a thing of the past with the development of nanomedicines.
Nanotechnology is a branch of science that deals with particles less than 100 nanometres (0.00001-centimetres) in size. Applying nanotechnology to medicine makes sense, since the molecular building blocks of the human body, as well as of many viruses and other disease-causing agents, are measured at the nanoscale.
European Nanomedicine Characterisation Laboratory (EUNCL)